AQP4 and myeloid sarcoma: This underscores the importance of AQP4-IgG testing in patients having overlapping NMOSD and MS symptoms with short lesions to avoid MS misdiagnosis and, consequently, the use of therapies that might aggravate NMOSD in an account of the non-appreciation of the potential of short transverse myelitis to occur in NMOSD.